Advertisement
Home »

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer.

Mar 27, 2023

ABOUT THE EXPERTS

  • Philipp Harter

    Department of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Henricistrasse 92, 45136 Essen, Germany. Electronic address: p.harter@kem-med.com.

    Gerhard Bogner

    Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, Salzburg, Austria.

    Luis Chiva

    Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain.

    David Cibula

    Department of Obstetrics and Gynecology, General University Hospital in Prague, First Faculty of Medicine, Charles University, Prague, Czech Republic.

    Nicole Concin

    Department of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Henricistrasse 92, 45136 Essen, Germany; Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria.

    Christina Fotopoulou

    Departments of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.

    Antonio Gonzalez-Martin

    Medical Oncology Department Clínica Univerdad de Navarra, Madrid, and Program in Solid Tumours CIMA, Pamplona, Spain.

    Frederic Guyon

    Institut Bergonié, Bordeaux, France.

    Viola Heinzelmann-Schwarz

    University Hospital Basel, Basel, Switzerland.

    Frederic Kridelka

    Department of Obstetrics and Gynaecology, CHU de Liège, Liège, Belgium.

    Sven Mahner

    Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.

    Frederik Marmé

    Department of Gynecologic Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

    Christian Marth

    Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria.

    Philippe Morice

    Institut Gustave-Roussy, Villejuif, France.

    Zoltán Novák

    Department of Gynaecology, National Insitute of Oncology, Budapest, Hungary.

    Andrea Papadia

    Department of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, Lugano, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.

    Isabelle Ray-Coquard

    Centre Léon Bérard, Lyon, France.

    Mikuláš Redecha

    II. department of gynaecology and obstetrics, University Hospital Bratislava, Comenius University, Bratislava, Slovakia.

    Andres Redondo

    Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.

    Richard Schwameis

    Division of General Gynecology and Gynecologic Oncology, Department of Obstetrics and Gynecology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

    Jalid Sehouli

    Department of Gynecology with Center of Gynecological Oncology,Charité, University Medicine of Berlin, Berlin, Germany.

    Manuela Undurraga

    University Hospital Geneva (HUG), Geneva, Switzerland.

    Toon Van Gorp

    Division of Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.

    Ignace Vergote

    Division of Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement